Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy.
D000284:Administration, Oral; D000328:Adult; D002784:Cholesterol / Q000097:blood; D002914:Chylomicrons / Q000097:blood; D005474:Fluoxymesterone / Q000008:administration & dosage* / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008055:Lipids / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014280:Triglycerides / Q000097:blood; D014511:Uremia / Q000150:complications / Q000378:metabolism*
D002914:Chylomicrons; D008055:Lipids; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002784:Cholesterol; D005474:Fluoxymesterone; D005947:Glucose